Sources | Names Used |
---|---|
CTRPv2 | SNX-2112:bortezomib (250:1 mol/mol) |
PharmacoGx | SNX-2112:bortezomib (250:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | DDX31 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.01 |
mRNA | NOC3L | CTRPv2 | pan-cancer | AAC | 0.082 | 0.01 |
mRNA | ZNF124 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.01 |
mRNA | KLRG1 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.01 |
mRNA | ATP11C | CTRPv2 | pan-cancer | AAC | 0.085 | 0.01 |
mRNA | TPRA1 | CTRPv2 | pan-cancer | AAC | -0.083 | 0.01 |
mRNA | AJUBA | CTRPv2 | pan-cancer | AAC | -0.095 | 0.01 |
mRNA | GTF2H2 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.01 |
mRNA | MELK | CTRPv2 | pan-cancer | AAC | 0.083 | 0.01 |
mRNA | MYC | CTRPv2 | pan-cancer | AAC | 0.09 | 0.01 |